Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation [NA]

View source ↗

Summary

A completed clinical trial update for FLOW EVAL-AF evaluating FLOW Mapping Electrogram Validation in patients with persistent atrial fibrillation, with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ablacon, Inc. | Conditions: Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2024-05-16